This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: North Carolina State University, Southern Illinois University, The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 2026.
Company Filing History:
1 out of 1,488 
1 out of 114 
1 out of 3,690 
Years Active: 2026
Title: Innovations of Isaiah Adelabu in Hyperpolarization Technology
Introduction
Isaiah Adelabu is an accomplished inventor based in Detroit, MI (US). He has made significant contributions to the field of hyperpolarization technology, particularly in the development of methods that enhance imaging techniques for medical diagnostics. His work focuses on improving the monitoring and diagnosis of diseases, including various cancers and metabolic disorders.
Latest Patents
Isaiah Adelabu holds a patent for a "Temperature cycling method for hyperpolarization of target molecules and contrast agents using parahydrogen." This innovative method provides hyperpolarized target molecules and contrast agents, along with methods for their production and imaging applications. The techniques he developed are cryogen-free, cost-effective, and can be executed in a short time frame, making them highly practical for real-time medical applications.
Career Highlights
Throughout his career, Isaiah has worked with notable institutions such as Wayne State University and Southern Illinois University. His experience in these academic environments has allowed him to advance his research and contribute to the scientific community significantly.
Collaborations
Isaiah has collaborated with esteemed colleagues, including Thomas Theis and Eduard Y Chekmenev. These partnerships have further enriched his research and innovation efforts in the field of hyperpolarization.
Conclusion
Isaiah Adelabu's work in hyperpolarization technology exemplifies the intersection of innovation and practical application in medical diagnostics. His contributions are paving the way for advancements in real-time disease monitoring and diagnosis.